Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ORAI1 | Q96D31 | 2/20 | 0.40 |
| ▸ | ORAI2 | Q96SN7 | 2/20 | 0.40 |
| ▸ | ORAI3 | Q9BRQ5 | 2/20 | 0.40 |
| ▸ | TRPV6 | Q9H1D0 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 4/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | THRB | P10828 | 2/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.36 |
| ▸ | CA4 | P22748 | 2/20 | 0.36 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.36 |
| ▸ | PCSK9 | Q8NBP7 | 1/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28230966 | 0.87 | ORAI1 (0.34) | ORAI1ORAI2ORAI3TRPV6LMNA | |
| SCHEMBL28243261 | 0.87 | ORAI1 (0.39) | ORAI1ORAI2ORAI3TRPV6LMNA | |
| SCHEMBL28346862 | 0.87 | CA4 (0.36) | ORAI1ORAI2ORAI3TRPV6LMNA | |
| SCHEMBL13476067 | 0.80 | ORAI1 (0.52) | ORAI1ORAI2ORAI3TRPV6LMNA | |
| SCHEMBL442588 | 0.76 | TRPV6 (0.44) | ORAI1ORAI2ORAI3TRPV6LMNA | |
| SCHEMBL3955823 | 0.75 | ORAI1 (0.40) | ORAI1ORAI2ORAI3TRPV6KMT2A | |
| SCHEMBL28781826 | 0.74 | — | — | |
| SCHEMBL8303050 | 0.71 | ORAI1 (0.37) | ORAI1ORAI2ORAI3TRPV6CA4 | |
| SCHEMBL3734405 | 0.70 | ALDH1A1 (0.36) | ORAI1ORAI2ORAI3TRPV6LMNA | |
| SCHEMBL3894047 | 0.65 | ADH1B (0.39) | LMNAKMT2ATDP1MEN1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026042111-A1 | TEMPERATURE- AND PH-SENSITIVE, BPA-TARGETED, CHITOSAN–POLY(N-ISOPROPYLACRYLAMIDE)–FPBA CORE-SHELL POLYMERIC NANOPARTICLES CAPABLE OF FORMING COF STRUCTURES FOR USE IN THE BNCT THERAPEUTIC METHOD. | SOLEIMANBEIGI MONIREH (IR) | 2026-02-26 | — | — | WO | claimed |
| CN-118388783-A | Molecularly imprinted covalent organic framework composite material based on acid-induced color, preparation method and application thereof | 浙江树人学院 | 2024-07-26 | — | — | CN | claimed |
| US-10435418-B2 | Rapid and efficient bioorthogonal ligation reaction and boron-containing heterocycles useful in conjunction therewith | The Research Foundation for the State University o (US) | 2019-10-08 | — | — | US | claimed |
| US-20180065993-A1 | RAPID AND EFFICIENT BIOORTHOGONAL LIGATION REACTION AND BORON-CONTAINING HETEROCYCLES USEFUL IN CONJUNCTION THEREWITH | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK | 2018-03-08 | — | — | US | claimed |
| US-9758533-B2 | Rapid and efficient bioorthogonal ligation reaction and boron-containing heterocycles useful in conjunction therewith | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2017-09-12 | — | — | US | claimed |
| EP-3134418-A1 | A RAPID AND EFFICIENT BIOORTHOGONAL LIGATION REACTION AND BORON-CONTAINING HETEROCYCLES USEFUL IN CONJUCTION THEREWITH | The Research Foundation for The State University of New York (US) | 2017-03-01 | — | — | EP | claimed |
| US-20150329568-A1 | RAPID AND EFFICIENT BIOORTHOGONAL LIGATION REACTION AND BORON-CONTAINING HETEROCYCLES USEFUL IN CONJUNCTION THEREWITH | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-11-19 | — | — | US | claimed |
| WO-2015164213-A1 | A RAPID AND EFFICIENT BIOORTHOGONAL LIGATION REACTION AND BORON-CONTAINING HETEROCYCLES USEFUL IN CONJUCTION THEREWITH | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2015-10-29 | — | — | WO | claimed |
| EP-4634219-A1 | HIGH STRENGTH LIQUID PROTEASE FORMULATIONS | Novozymes A/S (DK) | 2025-10-22 | — | — | EP | disclosed |
| CN-119241850-A | High-toughness heat-resistant self-repairing organic silicon elastomer material and preparation method thereof | 杭州师范大学 | 2025-01-03 | — | — | CN | disclosed |
| CN-118388783-A | Molecularly imprinted covalent organic framework composite material based on acid-induced color, preparation method and application thereof | 浙江树人学院 | 2024-07-26 | — | — | CN | disclosed |
| WO-2024126697-A1 | HIGH STRENGTH LIQUID PROTEASE FORMULATIONS | NOVOZYMES A/S (DK) | 2024-06-20 | — | — | WO | disclosed |
| CN-117771449-A | Self-repairable composite anti-adhesion material, and preparation method and application thereof | 烟台先进材料与绿色制造山东省实验室 | 2024-03-29 | — | — | CN | disclosed |
| CN-112206219-B | Preparation and application of glucose-sensitive insulin delivery system | 沈阳药科大学 | 2022-09-23 | — | — | CN | disclosed |
| WO-2004056315-A2 | COMPOSITIONS AND METHODS FOR STABILIZING TRANSTHYRETIN AND INHIBITING TRANSTHYRETIN MISFOLDING | THE SCRIPPS RESEARCH INSTITUTE (US) | 2004-07-08 | — | — | WO | disclosed |
| US-6652608-B1 | Fuel compositions exhibiting improved fuel stability | OCTANE INTERNATIONAL, LTD. | 2003-11-25 | — | — | US | disclosed |
| EP-1051461-A2 | FUEL COMPOSITIONS EMPLOYING CATALYST COMBUSTION STRUCTURE | ORR, William C. (US) | 2000-11-15 | — | — | EP | disclosed |
| WO-1999066009-A2 | FUEL COMPOSITIONS EMPLOYING CATALYST COMBUSTION STRUCTURE | ORR WILLIAM C (US) | 1999-12-23 | — | — | WO | disclosed |
| EP-0954558-A1 | FUEL COMPOSITIONS EXHIBITING IMPROVED FUEL STABILITY | ORR, William C. (US) | 1999-11-10 | — | — | EP | disclosed |
| WO-1998026028-A1 | FUEL COMPOSITIONS EXHIBITING IMPROVED FUEL STABILITY | ORR WILLIAM C (US) | 1998-06-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180065993-A1 | RAPID AND EFFICIENT BIOORTHOGONAL LIGATION REACTION AND BORON-CONTAINING HETEROCYCLES USEFUL IN CONJUNCTION THEREWITH | BLVRB, BTD, BCAT1 | ORAI1 3309/4885ORAI2 3920/4885ORAI3 3534/4885 |
| US-10435418-B2 | Rapid and efficient bioorthogonal ligation reaction and boron-containing heterocycles useful in conjunction therewith | BLVRB, BTD, BCAT1 | ORAI1 3309/4885ORAI2 3920/4885ORAI3 3534/4885 |
| US-20150329568-A1 | RAPID AND EFFICIENT BIOORTHOGONAL LIGATION REACTION AND BORON-CONTAINING HETEROCYCLES USEFUL IN CONJUNCTION THEREWITH | BLVRB, BCAT1, BCAT2 | ORAI1 3176/4885ORAI2 4179/4885ORAI3 3744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.